Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.

Blood cancers such as leukemia, lymphoma, and myeloma often begin in the bone marrow and disrupt normal blood cell formation.

Johns Hopkins scientists discovered a way to convert “immune-cold” tumors into “immune-hot” ones by activating key immune ...

As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive ...

Rather than working on the surface of cells like some cancer medicines, small molecules are able to slip inside the cell to ...

The scientists named this new process ER3D, which stands for endogenous RNA-directed DNA damage. It’s the first time ...

Cancer treatments don't always work as expected, leaving patients to suffer side effects of chemotherapy without gaining ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

Providence Cancer Institute’s executive medical director, Bryan Bell, M.D., D.D.S, FACS, FRCS(Ed), recently discussed recent ...

Zeaxanthin, best known for eye health, has been found to boost the tumor-killing power of T cells. Researchers showed it ...